Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

2(40.0%)

Phase 2

2(40.0%)

N/A

1(20.0%)

5Total

Phase 1(2)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06650644Not ApplicableCompleted

A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children With Autism Spectrum Symptoms.

Role: collaborator

NCT04911751Phase 2Completed

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

Role: lead

NCT04898348Phase 2Withdrawn

A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

Role: lead

NCT04056130Phase 1Completed

A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Role: lead

NCT04307173Phase 1Completed

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Role: lead

All 5 trials loaded